Reported 2 days ago
iRhythm Technologies, Inc. (NASDAQ:IRTC) has emerged as one of the best-performing healthcare stocks with a year-to-date performance of 52.71%. The company specializes in digital healthcare solutions for cardiac monitoring, benefiting from the robust demand for its Zio AT product. Analyst William Plovanic maintains a Buy rating on iRhythm, citing strong revenue growth and an optimistic outlook for the fiscal year. The recent executive order from President Trump focused on healthcare cost reductions further highlights the favorable market conditions for companies like iRhythm.
Source: YAHOO